期刊文献+

自身免疫性肝炎-原发性胆汁性肝硬化重叠综合征12例临床分析 被引量:9

Clinical Analysis of 12 Patients with Autoimmune Hepatitis-Primary Biliary Cirrhosis Overlap Syndrome
下载PDF
导出
摘要 目的初步探讨自身免疫性肝炎和原发性胆汁性肝硬化重叠综合征(AIH-PBC OLS)的临床特点。方法回顾性总结北京军区总医院近10年收治12例AIH-PBC临床表现、血清生化指标和免疫指标以及病理及治疗。结果 AIH-PBC OLS临床表现缺乏特异性,主要有乏力、低热、黄疸、皮肤瘙痒等;肝脏酶学指标ALT、AST、ALP、GGT、IgM、IgG均明显升高,肝穿刺病理也显示肝细胞坏死、汇管区炎细胞浸润,同时可见小胆管损伤。治疗上倾向以UDCA与皮质激素或免疫抑制剂联合用药。结论 AIH-PBC OLS不完全等同于典型的AIH或者PBC,而更像是两种疾病的同时叠加,临床应严密监控,随时调整治疗方案。 Objective To explore clinical features of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome( AIH-PBC OLS). Methods Clinical manifestations,serous biochemical indicators,immune indicators,clinical data of pathological changes and treatments of 12 patients with AIH-PBC OLS in last 10 years were retrospectively summarized. Results Clinical manifestations of AIH-PBC OLS were non-specific in terms of fatigue,low-grade fever,jaundice and pruritus,etc. Hepatic enzymology indexes of ALT,AST,ALP,GGT,IgM and IgG were significantly elevated,and pathological tests of liver biopsy showed hepatocellular damage such as piecemeal necrosis and lymphocytic infiltrates, and simultaneous biliary duct injuries. UDCA combined with corticosteroids or immunosuppressive agents was recommended in the treatment for AIH- PBC OLS. Conclusion The AIH-PBC OLS has relatively specific features,and the manifestations are not similar to those of typical AIH or PBC,but more of manifestations of the two coexisting diseases. So it is necessary to monitor the clinical status closely and adjust treatment protocols.
出处 《解放军医药杂志》 CAS 2013年第12期78-79,82,共3页 Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
关键词 肝炎 自身免疫性 肝硬化 胆汁性 诊断 Hepatitis,autoimmunity Liver cirrhosis,biliary Diagnosis
  • 相关文献

参考文献14

二级参考文献21

  • 1贾继东.自身免疫性肝病的临床诊断和治疗概况[J].中国医刊,2005,40(1):3-5. 被引量:6
  • 2无.慢性乙型肝炎防治指南[J].实用肝脏病杂志,2006,9(1):8-18. 被引量:825
  • 3王燕,窦恒利,耿红莲,钱王争,梁艳,陆慧琦,朱烨,仲人前.增殖诱导配体在自身免疫病患者外周血中的表达[J].现代免疫学,2006,26(5):408-412. 被引量:2
  • 4梁艳,杨再兴,朱烨,王燕,曾贤铭,邓安梅,仲人前.B细胞激活因子受体家族基因表达与原发性胆汁性肝硬化相关性研究[J].中华医学杂志,2007,87(2):128-130. 被引量:1
  • 5Lindor KD,Gershwin ME,Poupon R,et al.AASLD practice guideline:primary biliary cirrhosis[J] ,Hepatol,2009,50(1):291-308.
  • 6Lyttkens K,Prytz H,Forsberg L,et al.Hepatic lymph nodes as follow-up factor in primary biliary cirrhosis.An Ultrasound Study[J].Scand J Gastroenteral,1995,30(10):36-40.
  • 7Dietrich CF,Leuschner MS,Zeuzem S,et al.Peri-hepatic lymphadenopathy in primary biliary cirrhosis reflects progression of the disease[J].Eur J Gastroenterol Hepatol,1999,11(7):47-53.
  • 8Krawitt EL. Autoimmune hepatitis[J]. N Engl J Med, 2006, 354(1) :54-66.
  • 9Czaja AJ, Freese DK. American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis [J]. Hepatology,2002,36(2) :479-497.
  • 10Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review o: criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol, 1999,31 (5) : 929-938.

共引文献13

同被引文献102

引证文献9

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部